New Alzheimer's drug breeds skepticism
The first new Alzheimer's treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout has been slowed by que…
The first new Alzheimer's treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout has been slowed by que…